🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.1465
-0.0135 (-8.44%)
At close: Nov 18, 2026, 4:00 PM EST
0.1485
+0.0020 (1.37%)
After-hours: Nov 18, 2026, 7:07 PM EST

Mangoceuticals Statistics

Total Valuation

Mangoceuticals has a market cap or net worth of $3.26 million. The enterprise value is $3.23 million.

Market Cap3.26M
Enterprise Value 3.23M

Important Dates

The last earnings date was Monday, November 16, 2026, after market close.

Earnings Date Nov 16, 2026
Ex-Dividend Date n/a

Share Statistics

Mangoceuticals has 22.22 million shares outstanding. The number of shares has increased by 137.76% in one year.

Current Share Class 22.22M
Shares Outstanding 22.22M
Shares Change (YoY) +137.76%
Shares Change (QoQ) +19.30%
Owned by Insiders (%) 23.27%
Owned by Institutions (%) 10.20%
Float 16.09M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.84
Forward PS n/a
PB Ratio 0.29
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 10.76
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.05.

Current Ratio 1.28
Quick Ratio 0.57
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -471.56

Financial Efficiency

Return on equity (ROE) is -75.04% and return on invested capital (ROIC) is -40.56%.

Return on Equity (ROE) -75.04%
Return on Assets (ROA) -38.68%
Return on Invested Capital (ROIC) -40.56%
Return on Capital Employed (ROCE) -70.21%
Weighted Average Cost of Capital (WACC) 13.88%
Revenue Per Employee $100,161
Profits Per Employee -$4.07M
Employee Count3
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -88.37% in the last 52 weeks. The beta is 2.15, so Mangoceuticals's price volatility has been higher than the market average.

Beta (5Y) 2.15
52-Week Price Change -88.37%
50-Day Moving Average 0.33
200-Day Moving Average 0.39
Relative Strength Index (RSI) 24.80
Average Volume (20 Days) 843,677

Short Selling Information

The latest short interest is 53,343, so 0.24% of the outstanding shares have been sold short.

Short Interest 53,343
Short Previous Month 91,564
Short % of Shares Out 0.24%
Short % of Float 0.33%
Short Ratio (days to cover) 0.10

Income Statement

In the last 12 months, Mangoceuticals had revenue of $300,484 and -$12.21 million in losses. Loss per share was -$0.72.

Revenue300,484
Gross Profit 159,088
Operating Income -9.79M
Pretax Income -11.04M
Net Income -12.21M
EBITDA -8.46M
EBIT -9.79M
Loss Per Share -$0.72
Full Income Statement

Balance Sheet

The company has $659,258 in cash and $637,785 in debt, with a net cash position of $21,473 or $0.00 per share.

Cash & Cash Equivalents 659,258
Total Debt 637,785
Net Cash 21,473
Net Cash Per Share $0.00
Equity (Book Value) 13.69M
Book Value Per Share 0.51
Working Capital 328,389
Full Balance Sheet

Cash Flow

Operating Cash Flow -3.80M
Capital Expenditures n/a
Depreciation & Amortization 1.33M
Net Borrowing 240,500
Free Cash Flow -3.80M
FCF Per Share -$0.17
Full Cash Flow Statement

Margins

Gross Margin 52.94%
Operating Margin -3,258.24%
Pretax Margin -3,673.73%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Mangoceuticals does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -137.76%
Shareholder Yield -137.76%
Earnings Yield -490.17%
FCF Yield -116.69%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on October 16, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date Oct 16, 2024
Split Type Reverse
Split Ratio 1:15

Scores

Altman Z-Score n/a
Piotroski F-Score 2